Literature DB >> 22675012

Life-threatening retro-pharyngeal bleed in a case of systemic lupus erythematosus--an uncommon but important evil of a common disease.

Amruth Palla1, John Rogers, Sindhu Singh.   

Abstract

Acquired inhibitors of coagulation are antibodies that interfere with the coagulation system either by functional inhibition of the activity of clotting factors or by their increased clearance from the plasma. They can be idiopathic or seen in various physiologic (pregnancy and postpartum) or pathologic states (systemic lupus erythematosus (SLE), malignancies, rheumatoid arthritis) and can result in a variety of haemorrhagic sequelae. SLE can be associated with antibodies to multiple clotting factors and bleeding though rare can be an important haematologic manifestation with life-threatening consequences in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22675012      PMCID: PMC3207747          DOI: 10.1136/bcr.08.2011.4627

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

Review 1.  [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].

Authors:  E Liozon; L Delaire; P Turlure; A Jaccard; V Loustaud-Ratti; L Réméniéras; A Julia; S Gaillard; D Bordessoule; E Vidal
Journal:  Ann Med Interne (Paris)       Date:  1997

2.  Abnormal platelet function by acquired circulating factor VIII inhibitor in a patient with systemic lupus erythematosus.

Authors:  M Cortellaro; E Pogliani; E Cofrancesco
Journal:  Haematologica       Date:  1977-06       Impact factor: 9.941

3.  Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.

Authors:  P A Holme; F Brosstad; G E Tjønnfjord
Journal:  Haemophilia       Date:  2005-09       Impact factor: 4.287

4.  Rupture of the gallbladder in a patient with acquired factor VIII inhibitors and systemic lupus erythematosus.

Authors:  Sachiko Onishi; Nobumasa Hojo; Ikuya Sakai; Masaki Yasukawa; Takaaki Hato; Youko Minamoto; Eisuke Yokota; Mitsuko R Ito; Kentaro Dote; Ichiro Shimizu; Kazuo Nakanishi; Shigeru Fujita
Journal:  Intern Med       Date:  2004-11       Impact factor: 1.271

Review 5.  Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination.

Authors:  Y-Y Luo; G-S Zhang
Journal:  Haemophilia       Date:  2011-02-15       Impact factor: 4.287

Review 6.  Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature.

Authors:  D Erkan; H Bateman; M D Lockshin
Journal:  Lupus       Date:  1999       Impact factor: 2.911

7.  Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission.

Authors:  G Porru; V Mura; M Piga; V Ibba; A Vacca; A Cauli; G Passiu; R Targhetta; F Marongiu; A Mathieu
Journal:  Clin Rheumatol       Date:  2008-09-27       Impact factor: 2.980

8.  The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients.

Authors:  H Zeitler; G Ulrich-Merzenich; G Goldmann; N Vidovic; H H Brackmann; J Oldenburg
Journal:  Haemophilia       Date:  2008-11-14       Impact factor: 4.287

9.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

Review 10.  Acquired factor XI inhibitor in systemic lupus erythematosus--case report and literature review.

Authors:  Rodrigo Bortoli; Odirlei A Monticielo; Rafael M Chakr; Penélope E Palominos; Liane M Rohsig; Charles L Kohem; Ricardo M Xavier; João Carlos T Brenol
Journal:  Semin Arthritis Rheum       Date:  2008-06-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.